Shopping Cart
- Remove All
- Your shopping cart is currently empty
UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $2,258 | 8-10 weeks | |
50 mg | $2,980 | 8-10 weeks | |
100 mg | $4,000 | 8-10 weeks |
Description | UDM-001651 is an effective and orally bioavailable protease-activated receptor 4 antagonists (IC50=4 nM; Kd=1.4 nM). UDM-001651 displays antiplatelet potency (IC50=25 nM) in a γ-thrombin-induced platelet-rich plasma aggregation assay. |
Targets&IC50 | PAR4:(kd)1.4 nM, PAR4:4 nM |
Molecular Weight | 513.56 |
Formula | C28H23N3O5S |
Cas No. | 1477497-01-0 |
Relative Density. | 1.36 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.